Company: ATRA
Filing Date: 2025-03-07
Form Type: 10-K
Source: 0000950170-25-035507
Chunk: 1

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-03-07
Form: 10-K
Item: Item 15
Chunk 1
---
(a)(1)	Financial Statements.

The response to this portion of Item 15 is set forth under Item 8 above.

(a)(2)	Financial Statement Schedules.

All schedules have been omitted because they are not required or because the required information is given in the financial statements or notes thereto set forth under Item 8 above.

(a)(3)	Exhibits.

134

EXHIBIT INDEX

    Exhibit

    Incorporated by Reference
     
    Filed

    Number
     
    Exhibit Description
     
    Form

    Exhibit
     
    Filing Date
     
    Herewith

      3.1
     
    Amended and Restated Certificate of Incorporation of Atara Biotherapeutics, Inc.
     
    S-1

    3.2
     
    06/20/2014

      3.2
     
    Third Amended and Restated Bylaws of Atara Biotherapeutics, Inc.
     
    8-K

    3.1
     
    12/23/2024

      4.1
     
    Form of Common Stock Certificate
     
    S-1/A

    4.1
     
    07/10/2014

      4.2
     
    Form of 2019 Pre-Funded Warrant
     
    8-K

    4.1
     
    07/22/2019

      4.3
     
    Form of May 2020 Pre-Funded Warrant
     
    8-K

    4.1
     
    05/28/2020

      4.4
     
    Form of December 2020 Pre-Funded Warrant
     
    8-K

    4.1
     
    12/09/2020

      4.5
     
    Form of September 2024 Pre-Funded Warrant
     
    8-K

    4.1
     
    09/03/2024

      4.6
     
    Description of Securities

    X

    10.1*
     
    Amended and Restated 2014 Equity Incentive Plan
     
    10-Q

    10.2
     
    08/08/2016

    10.2*
     
    Forms of Option Agreement and Option Grant Notice under the 2014 Equity Incentive Plan
     
    S-1